Press Enter to search · Esc to close
Fresh cohort analyses say the perioperative picture is procedure-specific — reassuring at the hip, worrying at the shoulder — and shortages keep complicating the calculus.
Semaglutide and tirzepatide are reshaping body composition for millions of lifters and dieters. A cluster of 2025 reports is starting to map what happens when these drugs collide with surgery, scopes, and scans.
A retrospective hip-replacement study suggests non-diabetic GLP-1 users may not face the malnutrition penalty surgeons feared — but the questions are bigger than one paper.